What Members Need to Know
The Pandemic and All-Hazards Preparedness and Innovation Act of 2019 was signed into law by President Trump on June 24, 2019. HIDA Government Affairs worked with congressional champions to include language for the first time around healthcare supply chain priorities. The bill reauthorized a number of programs with respect to public health security and all-hazards preparedness and response. As a result of the legislation, more focus will be given to:
Communicating regional health systems to the supply chain
- Government coordination with the commercial market on response, re-entry and understanding manufacturing capacity
- Assessing ancillary product availability for medical countermeasures
- Identification of product substitutes.
These provisions build on supply chain lessons from past events to support future public health responses. Medical products are critical to any emergency or pandemic response. Ensuring the elasticity of the supply chain is essential to a prepared national healthcare system and is stronger through a public and private partnership.